Yellow

VITRAKVI® is an oral medicine that is not a chemotherapy

  • VITRAKVI is the first medicine specifically designed to block TRK proteins
  • VITRAKVI is thought to work by blocking these proteins and stopping cancer cells from growing, but the exact way VITRAKVI works is unknown
  • VITRAKVI can work in a variety of tumor types as long as the tumor is caused by an NTRK gene fusion
card

Are you and your doctor considering treatment with VITRAKVI?

Before you can take VITRAKVI, your healthcare provider will perform a test to make sure that VITRAKVI is right for you.

women
Learn More About TRK Fusion Cancer and Testing
card

Have you been prescribed VITRAKVI?

VITRAKVI was exclusively designed to treat TRK fusion cancer.

father daughter
See How VITRAKVI Has
Helped Patients
voices

VITRAKVI Voices: Your story can inspire others

If you are a patient currently taking VITRAKVI or are a caregiver, we would love to hear about your personal experience.

Let’s Keep in Touch

Let’s Keep in Touch

If you would like more information and the latest news about VITRAKVI, register now to receive future updates.

Register for Updates